Intensive Antiplatelet Therapy to Improve Outcomes in Patients with Acute Coronary Syndrome

Intensive Antiplatelet Therapy to Improve Outcomes in Patients with Acute Coronary Syndrome is organized by the AcademicCME.

Program Dates: January 31, 2020 - January 30, 2021

Accreditation:
AcademicCME designates this live material for a maximum of 1.5 AMA PRA Category 1 Credits™.

Program Overview:
This CME program will highlight recent advances in intensive antiplatelet therapy to improve outcomes in patients with acute coronary syndrome (ACS). The expert faculty, led by Dr. Christopher P. Cannon, will review platelet inhibition science as well as unmet needs in ACS. Following, recent clinical trial data, including outcomes data, will be analyzed and clinical relevance debated in an interactive panel format. Best practices for providing individualized, long-term treatment for patients will be outlined, including the role of aspirin in ACS care. Upon completing this CME activity, learners will be better equipped to treat and manage their patients with acute coronary syndrome.

Learning Objectives:
• Review contemporary clinical trial data for intensive antiplatelet therapeutics to improve outcomes for patients with ACS
• Analyze optimal treatment plans for intensive antiplatelet therapy to improve outcomes in patients with ACS